New hope to stop wasting away during cervical cancer treatment
NCT ID NCT07338487
Summary
This study is testing whether a new form of an appetite-stimulating drug can help women with advanced cervical cancer maintain their weight and strength during combined chemotherapy and radiation treatment. The drug aims to break the cycle of severe weight loss and muscle wasting that often occurs, which can make treatment harder to tolerate and reduce survival chances. Researchers will compare women receiving the new drug alongside standard treatment to those receiving standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xiangya Second Hospital of Central South University
RECRUITINGChangsha, Hunan, 410011, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.